Exploring the Silent Connection Between Sleep Disorders (i.e., OSA, Insomnia) and Cardiovascular Diseases: Pathophysiology and Insights
Open Access
- 29 January 2025
- journal article
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 7 (1) , 1-11
Abstract
Sleep is a complex physiological phenomenon crucial for health. Despite this, millions suffer from sleep disorders, contributing to a range of health issues, particularly cardiovascular diseases (CVD). The pathophysiological mechanisms linking sleep disorders, such as insomnia and obstructive sleep apnea (OSA), to cardiovascular risk factors include disruptions in inflammatory, autonomic, and metabolic pathways. Increased sympathetic nervous system activity, chronic inflammation, and metabolic dysregulation stemming from poor sleep can lead to conditions like hypertension, obesity, and insulin resistance, significantly elevating the risk for CVD. This article reviews the connection between sleep quality and cardiovascular disease risks. Sleep disorders (i.e., insomnia and OSA) have been found to impact cardiovascular risk factors adversely. Studies have found an association between abnormal sleep and increased cardiovascular morbidity and mortality by higher risks of hypertension, diabetes, obesity, and dyslipidemia. The review also discusses non-pharmacological interventions, such as relaxation training, Cognitive behavioral therapy for insomnia (CBT-I), and red-light therapy, which have shown efficacy in improving sleep quality and reducing cardiovascular risks. Dual orexin receptor antagonists and Ashwagandha promise to enhance sleep quality and cardiovascular health, but further research is needed. Addressing sleep disorders and promoting healthy sleep practices are essential for mitigating the global burden of cardiovascular diseases, underscoring the need for continued research and effective public health interventions.Keywords
This publication has 60 references indexed in Scilit:
- Photobiomodulation therapy mitigates cardiovascular aging and improves survivalLasers in Surgery and Medicine, 2023
- Sleep duration and health outcomes: an umbrella reviewSleep and Breathing, 2021
- A double-blind, randomized, placebo-controlled trial on the effect of Ashwagandha (Withania somnifera dunal.) root extract in improving cardiorespiratory endurance and recovery in healthy athletic adultsJournal of Ethnopharmacology, 2021
- Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled studyJournal of Ethnopharmacology, 2021
- Patient-reported triggers of paroxysmal atrial fibrillationHeart Rhythm, 2019
- Sympathetic Nervous System, Sleep, and HypertensionCurrent Hypertension Reports, 2018
- The Orexin System and HypertensionCellular and Molecular Neurobiology, 2017
- OSA and Cardiac ArrhythmogenesisChest, 2017
- Sleep restriction increases free fatty acids in healthy menDiabetologia, 2015
- Relation of self-reported sleep duration with carotid intima-media thickness in a general population sampleAtherosclerosis, 2008